Drug Discovery
Hox Therapeutics and Vernalis Enter Collaboration to Advance Oncology Drug Discovery
Hox Therapeutics Ltd, a pioneering biotechnology company dedicated to developing targeted cancer therapies, and Vernalis (R&D) Ltd, a renowned subsidia...
February 22, 2024 | News
Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)
Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...
February 17, 2024 | News
FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors
Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...
February 15, 2024 | News
GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform
Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...
February 15, 2024 | News
Atara Biotherapeutics Submits Investigational New Drug Application for ATA3219 to Treat Lupus Nephritis
Lupus nephritis, a condition affecting the kidneys, presents a challenging treatment landscape with limited efficacy from existing therapies. ATA32...
February 15, 2024 | News
BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development
BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...
February 14, 2024 | News
VantAI and Bristol Myers Squibb Forge AI-Driven Partnership to Propel Molecular Glue Drug Discovery
VantAI, a trailblazer in artificial intelligence (AI)-enabled drug discovery, has announced a groundbreaking collaboration with pharmaceutical giant Bristo...
February 14, 2024 | News
Innovent Biologics Advances Novel Weight Management Drug Mazdutide with NDA Acceptance in China
This groundbreaking achievement marks mazdutide as the first GLP-1R/GCGR dual agonist to successfully complete Phase 3 trials in support of an NDA ...
February 08, 2024 | Regulatory
Pliant Therapeutics Reports Positive Results in Bexotegrast Trial for Liver Fibrosis
Bexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; No safety conce...
February 05, 2024 | News
Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology
The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...
February 01, 2024 | News
Vertex's Breakthrough VX-548: Transforming Pain Management with Rapid Relief and Safety, A New Era in Acute Pain Solutions
Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...
January 31, 2024 | News
Fresenius Kabi Launches Posaconazole Injection for Fungal Infection Prevention/Treatment
Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...
January 30, 2024 | News
Peijia Medical Completes Enrollment for TaurusTrio™ Aortic Regurgitation Trial
The multi-center trial utilized the TaurusTrioTM TAVR system to treat pure AR in 116 patients across 13 hospitals within China and is design...
January 30, 2024 | News
Ractigen Therapeutics Partners with Utrecht Medical Center for saRNA Innovation in Neurodevelopmental Disorders
Professor Bobby Koeleman, Group Leader at the Department of Genetics within the Center for Molecular Medicine at Utrecht University, will le...
January 30, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
